Ecolab Inc.: Form 10-Q for the period ended Mar 31, 2025
Filed with the SEC on May 8, 2025 and accepted by EDGAR at May 8, 2025, 16:08 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2025-01-01 to 2025-03-31 | $3.69bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2025-01-01 to 2025-03-31 | $2.06bn | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 3 months2025-01-01 to 2025-03-31 | $1.05bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2025-01-01 to 2025-03-31 | $555.3m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2025-01-01 to 2025-03-31 | $72.6m | us-gaap:InterestExpense |
| Income tax | 3 months2025-01-01 to 2025-03-31 | $103.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2025-01-01 to 2025-03-31 | $402.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2025-01-01 to 2025-03-31 | $1.41 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2025-01-01 to 2025-03-31 | $1.42 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2025-01-01 to 2025-03-31 | 285,300,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2025-01-01 to 2025-03-31 | $369.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2025-01-01 to 2025-03-31 | $237.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months2025-01-01 to 2025-03-31 | $192.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months2025-01-01 to 2025-03-31 | $153.7m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2025-03-31 | $1.16bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-03-31 | $6.08bn | us-gaap:AssetsCurrent |
| Total assets | At period end2025-03-31 | $22.37bn | us-gaap:Assets |
| Current liabilities | At period end2025-03-31 | $4.61bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-03-31 | $13.46bn | us-gaap:Liabilities |
| Current portion of debt | At period end2025-03-31 | $614.2m | us-gaap:DebtCurrent |
| Shareholders' equity | At period end2025-03-31 | $8.88bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2025-03-31 | 283,512,618 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001558370-25-006969. Last ingested by Listed: Oct 29, 2026, 16:39 ET. Listed shows no prices and gives no investment advice.